See more : Zee Entertainment Enterprises Limited (ZEEL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Pasithea Therapeutics Corp. (KTTAW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pasithea Therapeutics Corp., a leading company in the Biotechnology industry within the Healthcare sector.
- Samson Holding Ltd. (0531.HK) Income Statement Analysis – Financial Results
- IA Invest Strategic Danske Akti (IAISDKAKT.CO) Income Statement Analysis – Financial Results
- Path Investments Plc (PATH.L) Income Statement Analysis – Financial Results
- PT Intermedia Capital Tbk (MDIA.JK) Income Statement Analysis – Financial Results
- Mid-America Apartment Communities, Inc. (MAA) Income Statement Analysis – Financial Results
Pasithea Therapeutics Corp. (KTTAW)
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 486.56K | 15.06K | 0.00 |
| Cost of Revenue | 648.45K | 113.20K | 17.28K | 0.00 |
| Gross Profit | -648.45K | 373.36K | -2.21K | 0.00 |
| Gross Profit Ratio | 0.00% | 76.74% | -14.69% | 0.00% |
| Research & Development | 8.10M | 2.67M | 0.00 | 0.00 |
| General & Administrative | 7.88B | 9.92M | 0.00 | 0.00 |
| Selling & Marketing | -7.87B | 2.60M | 0.00 | 0.00 |
| SG&A | 7.88M | 12.52M | 4.51M | 40.98K |
| Other Expenses | 0.00 | 44.72K | 0.00 | 0.00 |
| Operating Expenses | 15.98M | 15.19M | 4.51M | 40.98K |
| Cost & Expenses | 15.98M | 15.30M | 4.52M | 40.98K |
| Interest Income | 0.00 | 102.00 | 508.00 | 0.00 |
| Interest Expense | 0.00 | 102.00 | 508.00 | 0.00 |
| Depreciation & Amortization | 648.45K | 5.09K | 1.38K | 61.48K |
| EBITDA | -15.33M | -12.58M | -4.51M | 0.00 |
| EBITDA Ratio | 0.00% | -3,029.28% | -29,916.57% | 0.00% |
| Operating Income | -15.98M | -14.82M | -4.51M | -40.98K |
| Operating Income Ratio | 0.00% | -3,045.12% | -29,925.73% | 0.00% |
| Total Other Income/Expenses | 471.61K | 861.09K | 2.33M | -4.00 |
| Income Before Tax | -15.51M | -13.94M | -2.17M | -40.98K |
| Income Before Tax Ratio | 0.00% | -2,864.29% | -14,430.49% | 0.00% |
| Income Tax Expense | 0.00 | -879.97K | 508.00 | -61.48K |
| Net Income | -15.96M | -13.06M | -2.17M | -40.98K |
| Net Income Ratio | 0.00% | -2,683.43% | -14,433.87% | 0.00% |
| EPS | -12.65 | -10.34 | -1.89 | -0.06 |
| EPS Diluted | -13.01 | -10.34 | -1.89 | -0.06 |
| Weighted Avg Shares Out | 1.26M | 1.26M | 1.15M | 688.92K |
| Weighted Avg Shares Out (Dil) | 1.23M | 1.26M | 1.15M | 688.92K |
Source: https://incomestatements.info
Category: Stock Reports